Navigation Links
BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
Date:2/6/2009

t." Findings presented in this poster support the evaluation of BCX-4208 in the treatment of not only T-cell mediated diseases, but also B-cell mediated diseases.

Corporate Developments

  • Stanley C. Erck was appointed to BioCryst's Board of Directors in December 2008. Mr. Erck joined the Company's Board with over 20 years of experience in the biotechnology industry, most recently having served as President and Chief Executive Officer of Iomai Corp. At Iomai, he led the company through an initial public offering, a merger with Intercell, an Austrian vaccine company, and through the development of a late-stage infectious disease product candidate. In addition to BioCryst, Mr. Erck currently serves on the Board of Directors of both MacCyte and MdBio Foundation.

Conference Call and Web Cast

BioCryst's management team will host a conference call and Web cast on Friday, February 6, 2009, at 8:30 a.m. Eastern Time to discuss the financial results and recent corporate developments. To participate in the conference call, please dial 1-800-860-2442 (United States) or 1-412-858-4600 (International). No passcode is needed for the call. The Web cast can be accessed by logging onto http://www.biocryst.com. Please connect to the Web site at least 15 minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary.

About BioCryst

BioCryst is a biopharmaceutical company that has developed a deep pipeline of novel therapeutics targeting major illnesses by employing crystallography and structure-based drug design. BioCryst is currently advancing investigational new drugs discovered in-house in late-stage clinical trials for influenza and lymphoma. In addition, the Company has a pre-clinica
'/>"/>

SOURCE BioCryst Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
2. BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
3. BioCryst to Present at UBS 2007 Global Life Sciences Conference
4. BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
5. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
6. BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
7. BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
8. William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
9. BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
10. BioCryst to Present at UBS 2008 Global Life Sciences Conference
11. BioCryst to Present at the JMP Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... July 29, 2014  The Society for Clinical ... updated program for the 9 th annual ... in Amelia Island , Florida.  The focus ... remains unchanged, however, the topics and format will ... opportunity among all stakeholders with a continued focus ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Second generation biofuels ... imposed by fossil fuels. However, as natural gas is very ... as they are not as valuable as they could be ... the difficulty financing projects, has made it difficult for renewable ... projects get off the ground. For these reasons, certain companies ...
(Date:7/29/2014)... July 29, 2014  Discovery Laboratories, Inc. (Nasdaq: ... a new standard of respiratory critical care, will report ... 5, 2014 before the open of the U.S. ... host a live teleconference and webcast at 9:00 a.m. ... call, Discovery Labs, management will discuss the 2014 ...
(Date:7/29/2014)... 29, 2014 A new report ... (types, applications and geography) - Size, Share, Global Trends, ... and Forecast, 2013 - 2020", suggests that the global ... by 2020 registering a CAGR of 11.1% from 2014 ... by the electro surgical devices in operative procedures by ...
Breaking Biology Technology:TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 2TransCelerate, Lilly, Pfizer, and FDA Highlight Collaborative Program at the Site Solutions Summit 3Renewable Waste Intelligence: Could Renewable Chemicals Be the Future for the Renewable Energy Industry? 2Discovery Labs to Report 2014 Second Quarter Financial Results and Hold Conference Call on Tuesday, August 5, 2014 at 9:00 a.m. Eastern Time 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 3
... TRANSPORTATION -- Gone hybrid . . . ... automobiles are now posted at the www.fueleconomy.gov web ... the U.S. Department of Energy and the U.S. Environmental Protection ... fuel economy list are hybrid electrics, led by the Toyota ...
... , WELLINGTON, Colo., Nov. 5 The endangered black-footed ferrets ... rare carnivore feeds on prairie dogs. The prairie ... die-offs in towns occur. The U.S. Fish & Wildlife ... been releasing trained, captive ferrets into their formerly native habitat. ...
... Imagenetix, Inc. (OTC Bulletin Board: IAGX), announced today that ... the Company,s story at the 2nd annual LD MICRO Conference ... Luxe Sunset in Los Angeles. , About LD MICRO , ... on finding undervalued companies in the micro-cap space. Since 2002, ...
Cached Biology Technology:November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2
(Date:7/29/2014)... Kent has shown for the first time how the ... could have a major impact on cancer therapy development. ... the mechanism whereby the physical properties of the internal ... are ,fine-tuned, to undertake different functions. , While some ... a framework for the cell, others are more dynamic, ...
(Date:7/29/2014)... babies latest research from the University of Adelaide ... brains of many preterm children can perform almost as well ... the University,s Robinson Research Institute has found that ... in early life, their cognitive abilities as a teenager can ... the results of the study, published in this month,s issue ...
(Date:7/29/2014)... different types of cell, including sperm, bacteria and ... flagella. These protrusions, about one-hundredth of a millimetre ... through fluid. Similar, shorter structures called cilia are ... they perform roles such as moving liquids over ... remarkably versatile: they transport mucus and expel pathogens ...
Breaking Biology News(10 mins):Preterm children's brains can catch up years later 2Microscopic rowing -- without a cox 2Microscopic rowing -- without a cox 3
... When faced with cancer, the immune system dispatches cells, called ... often fail to completely eliminate the tumor because theyre deactivated ... T cells. Past attempts to get rid of these regulatory ... many features with the killer T cells, making it difficult ...
... Black carbon, a form of particulate air pollution most ... and diesel exhaust, has a warming effect in the ... according to scientists in an upcoming review article in ... at UC San Diego atmospheric scientist V. Ramanathan and ...
... the Wellcome Trust has provided a number of promising ... Scientists at the University of Cambridge have identified a ... cells to "eat" the malformed proteins that lead to ... number of degenerative diseases marked by build up of ...
Cached Biology News:Black carbon pollution emerges as major player in global warming 2Black carbon pollution emerges as major player in global warming 3Promising new drug targets identified for Huntington's disease 2
... refrigerators, freezers, or liquid nitrogen. Conveniently sized to fit ... coding to project, user, lab, etc. Holes in the ... circulation. Supplied with 9 x 9 (12.7 mm cell) ... 13 x 13 x 5.1 cm H (5 1/4 ...
Recombinant Rhesus Monkey IFN-Alpha...
Homo sapiens HCLS1 associated protein X-1 Antigen: Recombinant Protein...
5,6 Carboxyfluorescein is conjugated to BSA (bovine serum albumin) protein through amide bonds....
Biology Products: